Blood glucose 116
Pro Research Analysisby 
Searched over 200M research papers
Blood Glucose Levels and Therapeutic Interventions
Synthetic Leptin Agonist and Blood Glucose Regulation
Research has shown that synthetic peptides derived from leptin can significantly impact blood glucose levels. A study on a synthetic peptide amide corresponding to amino acid residues 116-130 of mouse leptin, known as LEP-(116-130), demonstrated its ability to reduce blood glucose levels in ob/ob and db/db mice. Further refinement identified that the active sequence resides between amino acid residues 116-122, leading to the creation of a peptide named OB3. Administration of OB3 and its analogs, particularly [D-Leu-4]-OB3, normalized blood glucose levels to those comparable to wild-type control mice within two days of treatment initiation.
Blood Glucose Levels Post-Cardiac Arrest
The management of blood glucose levels following cardiac arrest is crucial for patient outcomes. A study examining blood glucose levels 12 hours after cardiac arrest found a strong non-linear association between blood glucose levels and neurological recovery. Blood glucose levels in the range of 116-143 mg/dl were associated with better survival and neurological outcomes compared to both lower and higher glucose levels. This suggests that maintaining blood glucose within this range could have significant therapeutic implications for post-resuscitation care.
Berberine and Blood Glucose in Type 2 Diabetes
Berberine (BBR) has been identified as an effective agent in lowering blood glucose levels in patients with type 2 diabetes mellitus (T2DM). BBR increases the expression of insulin receptors (InsR) and enhances insulin-stimulated phosphorylation, which improves glucose utility. Clinical studies have shown that BBR significantly lowers fasting blood glucose (FBG) and hemoglobin A1c levels, with efficacy comparable to metformin and rosiglitazone. Additionally, BBR has been effective in lowering FBG in patients with chronic hepatitis B and C who also have T2DM or impaired fasting glucose, indicating its broad therapeutic potential.
Blood Glucose Measurement Accuracy in ICU
Accurate blood glucose measurement is critical in the intensive care unit (ICU) for effective glycemic control. The methodology of blood glucose control, including the accuracy of blood glucose meters and the insulin titration protocol, plays a significant role in patient outcomes. Blood gas analyzers are considered the gold standard for glucose measurement in critically ill patients. New generation point-of-care blood glucose meters, when used with a clinically validated insulin dosing algorithm, may offer a feasible alternative for maintaining glycemic targets in the ICU.
Conclusion
Maintaining optimal blood glucose levels is essential for various medical conditions and interventions. Synthetic leptin agonists, such as OB3, show promise in normalizing blood glucose levels in diabetic models. Post-cardiac arrest care benefits from maintaining blood glucose levels within a specific range for better neurological outcomes. Berberine offers a potent alternative for managing blood glucose in T2DM patients, with additional benefits for those with chronic liver conditions. Accurate blood glucose measurement remains a cornerstone of effective glycemic control in critical care settings. These insights underscore the importance of targeted therapeutic strategies and precise monitoring in managing blood glucose levels.
Sources and full results
Most relevant research papers on this topic